T. Zhang

Dual inhibiting EGFR and VEGF pathways versus EGFR-TKIs alone in the treatment of advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

G. Chen, T. Zhang, R. Wang, 2016, Clinical and Translational Oncology.

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer.

T. Stockley, E. Chen, D. Graham, 2021, Lung cancer.

Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients

Zhe-feng Liu, Z. Mao, L. Bai, 2016, Clinical and Translational Oncology.